Literature DB >> 23703302

[Epidemiology of hospital-acquired infections in an adult intensive care unit: results of a prospective cohort study].

A Simonetti1, E Ottaiano, M V Diana, C Onza, M Triassi.   

Abstract

OBJECTIVE: We aimed to describe the pattern of nosocomial infections in an adult medical-surgical intensive care unit (ICU).
METHODS: A 2-year prospective cohort study of nosocomial infection surveillance in a 12 - bed adult medical and surgical ICU of the Federico II University Hospital in Naples, was carried out. Data were collected between January 2009 and December 2010 using the standard surveillance protocols and nosocomial infection site definitions of the National Healthcare Safety Network's ICU surveillance component.
RESULTS: Out of 768 patients hospitalized during this period, 434 with an ICU stay longer than 48 h were included in the study. Fifty-three patients acquired a total of 71 nosocomial infections; 55 (77,5%) ventilatorassociated pneumonia (VAP), 10 (14,1%), central-line-associated bloodstream infection (CLA-BSI) and 6 (8,4%) catheter-associated urinary tract infection (CA-UTI). The overall patient day rate was 12,9 patient days. The patient infection rate was 16,3 patients at risk. The mean VAP rate was 15,0/1.000 ventilator days, the CLA-BSI rate 2,9/1.000 central line days and the CA-UTI rate 1,2/1.000 catheter days. Of the nosocomial infections, 65 were Gram-negative, 6 Gram-positive and 5 fungal. The most frequent organism was Acinetobacter baumannii (61,9%), followed by Pseudomonas aeruginosa (22,5%), Enterococcus fecalis (4,2%) and Candida albicans (4,2%). The crude mortality was 35% among ICU-infected patients.
CONCLUSIONS: VAP was the most common nosocomial infection in our ICU. Gram-negative organisms were more commonly reported as etiologic agents of ICU infections.

Entities:  

Mesh:

Year:  2013        PMID: 23703302     DOI: 10.7416/ai.2013.1930

Source DB:  PubMed          Journal:  Ann Ig        ISSN: 1120-9135


  7 in total

1.  Molecular Detection of the Virulent ExoU Genotype of Pseudomonas aeruginosa Isolated from Infected Surgical Incisions.

Authors:  Noha A Hassuna
Journal:  Surg Infect (Larchmt)       Date:  2016-07-21       Impact factor: 2.150

2.  Characterization of Escherichia coli isolates from hospital inpatients or outpatients with urinary tract infection.

Authors:  Francisco Toval; Christian-Daniel Köhler; Ulrich Vogel; Florian Wagenlehner; Alexander Mellmann; Angelika Fruth; M Alexander Schmidt; Helge Karch; Martina Bielaszewska; Ulrich Dobrindt
Journal:  J Clin Microbiol       Date:  2013-11-13       Impact factor: 5.948

3.  Acinetobacter baumannii bacteremia, a rare complication of endoscopic retrograde cholagiopancreatography!

Authors:  Hadoun Jabri; Devang Sanghavi; Sarbajit Mukherjee; Ema Dzaka-Dizdarevic; Nkemakolam Iroegbu
Journal:  Avicenna J Med       Date:  2014-04

Review 4.  The Pseudomonas aeruginosa AlgZR two-component system coordinates multiple phenotypes.

Authors:  Yuta Okkotsu; Alexander S Little; Michael J Schurr
Journal:  Front Cell Infect Microbiol       Date:  2014-06-20       Impact factor: 5.293

5.  An assessment of ventilator-associated pneumonias and risk factors identified in the Intensive Care Unit.

Authors:  Mevlut Karatas; Sedat Saylan; Ugur Kostakoglu; Gurdal Yilmaz
Journal:  Pak J Med Sci       Date:  2016 Jul-Aug       Impact factor: 1.088

6.  Incidence, Microbiological Profile and Risk Factors of Healthcare-Associated Infections in Intensive Care Units: A 10 Year Observation in a Provincial Hospital in Southern Poland.

Authors:  Małgorzata Kołpa; Marta Wałaszek; Agnieszka Gniadek; Zdzisław Wolak; Wiesław Dobroś
Journal:  Int J Environ Res Public Health       Date:  2018-01-11       Impact factor: 3.390

7.  Pseudomonas aeruginosa AlgR Phosphorylation Status Differentially Regulates Pyocyanin and Pyoverdine Production.

Authors:  Alexander S Little; Yuta Okkotsu; Alexandria A Reinhart; F Heath Damron; Mariette Barbier; Brandon Barrett; Amanda G Oglesby-Sherrouse; Joanna B Goldberg; William L Cody; Michael J Schurr; Michael L Vasil; Michael J Schurr
Journal:  mBio       Date:  2018-01-30       Impact factor: 7.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.